These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 22844464

  • 1. The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.
    Wang B, Lindley LE, Fernandez-Vega V, Rieger ME, Sims AH, Briegel KJ.
    PLoS One; 2012; 7(7):e41355. PubMed ID: 22844464
    [Abstract] [Full Text] [Related]

  • 2. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, Blick T, Toh A, Hill P, Gilles C, Waltham M, Thompson EW.
    Breast Cancer Res; 2017 Jul 27; 19(1):86. PubMed ID: 28750639
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-7 targets T-Box 2 to inhibit epithelial-mesenchymal transition and invasiveness in glioblastoma multiforme.
    Pan CM, Chan KH, Chen CH, Jan CI, Liu MC, Lin CM, Cho DY, Tsai WC, Chu YT, Cheng CH, Chuang HY, Chiu SC.
    Cancer Lett; 2020 Nov 28; 493():133-142. PubMed ID: 32861705
    [Abstract] [Full Text] [Related]

  • 4. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells.
    Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q.
    J Biol Chem; 2011 Jul 22; 286(29):25992-6002. PubMed ID: 21596753
    [Abstract] [Full Text] [Related]

  • 5. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
    Lin YC, Lee YC, Li LH, Cheng CJ, Yang RB.
    J Cell Sci; 2014 Jan 01; 127(Pt 1):85-100. PubMed ID: 24213532
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q.
    BMC Cancer; 2015 Mar 05; 15():97. PubMed ID: 25884904
    [Abstract] [Full Text] [Related]

  • 7. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
    Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, Taya Y.
    Cancer Res; 2008 Jul 01; 68(13):5104-12. PubMed ID: 18593909
    [Abstract] [Full Text] [Related]

  • 8. Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion.
    Li J, Liu J, Li P, Mao X, Li W, Yang J, Liu P.
    J Exp Clin Cancer Res; 2014 Sep 02; 33(1):70. PubMed ID: 25178656
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells.
    Mon AM, MacKinnon AC, Traktman P.
    PLoS One; 2018 Sep 02; 13(9):e0203397. PubMed ID: 30180179
    [Abstract] [Full Text] [Related]

  • 10. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
    Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J.
    Oncogene; 2013 Dec 12; 32(50):5614-24. PubMed ID: 23955085
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.
    Wang XX, Zhu Z, Su D, Lei T, Wu X, Fan Y, Li X, Zhao J, Fu L, Dong JT, Fu L.
    Hum Pathol; 2011 Oct 12; 42(10):1410-9. PubMed ID: 21419475
    [Abstract] [Full Text] [Related]

  • 12. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O, Rodriguez-Vargas JM, Wadier N, Martin-Hernandez K, Vauchelles R, Magroun N, Tissier A, Schreiber V, Dantzer F.
    Oncotarget; 2016 Sep 27; 7(39):64109-64123. PubMed ID: 27579892
    [Abstract] [Full Text] [Related]

  • 13. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
    Burton LJ, Dougan J, Jones J, Smith BN, Randle D, Henderson V, Odero-Marah VA.
    Mol Cell Biol; 2017 Mar 01; 37(5):. PubMed ID: 27956696
    [Abstract] [Full Text] [Related]

  • 14. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
    Sehrawat A, Kim SH, Vogt A, Singh SV.
    Carcinogenesis; 2013 Apr 01; 34(4):864-73. PubMed ID: 23276794
    [Abstract] [Full Text] [Related]

  • 15. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T, Nyarko JN, Kuski K, Fehr K, Pennington PR, Truitt L, Freywald A, Lukong KE, Anderson DH, Mousseau DD.
    Cell Signal; 2014 Dec 01; 26(12):2621-32. PubMed ID: 25152370
    [Abstract] [Full Text] [Related]

  • 16. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.
    Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H.
    Oncogene; 2007 Feb 01; 26(5):711-24. PubMed ID: 16862183
    [Abstract] [Full Text] [Related]

  • 17. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N, Heck C, Tiede S, Yilmaz M, Christofori G.
    Breast Cancer Res; 2018 Oct 01; 20(1):118. PubMed ID: 30285803
    [Abstract] [Full Text] [Related]

  • 18. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
    Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, Kung HF, Song LB, Zeng MS.
    Mol Cancer; 2011 Jan 28; 10(1):10. PubMed ID: 21276221
    [Abstract] [Full Text] [Related]

  • 19. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells.
    Yokdang N, Hatakeyama J, Wald JH, Simion C, Tellez JD, Chang DZ, Swamynathan MM, Chen M, Murphy WJ, Carraway Iii KL, Sweeney C.
    Oncogene; 2016 Jun 02; 35(22):2932-47. PubMed ID: 26387542
    [Abstract] [Full Text] [Related]

  • 20. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF, Tascón R, Lago Huvelle MR, Novack G, Llorens MC, Dos Santos AF, Shortrede J, Cabanillas AM, Bal de Kier Joffé E, Labriola L, Peters MG.
    Oncotarget; 2016 Sep 13; 7(37):60133-60154. PubMed ID: 27507057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.